Compare · IQV vs NRC
IQV vs NRC
Side-by-side comparison of IQVIA Holdings Inc. (IQV) and NRC Health (NRC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IQV and NRC operate in Biotechnology: Commercial Physical & Biological Resarch (Health Care), so they compete in similar markets.
- IQV is the larger of the two at $45.62B, about 45.1x NRC ($1.01B).
- Over the past year, IQV is up 8.1% and NRC is up 59.1% - NRC leads by 51.0 points.
- IQV has been more active in the news (3 items in the past 4 weeks vs 2 for NRC).
- IQV has more recent analyst coverage (25 ratings vs 0 for NRC).
- Company
- IQVIA Holdings Inc.
- NRC Health
- Price
- $162.28+0.95%
- $17.18-0.66%
- Market cap
- $45.62B
- $1.01B
- 1M return
- -1.96%
- +0.73%
- 1Y return
- +8.11%
- +59.12%
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NYSE
- NASDAQ
- IPO
- 2013
- News (4w)
- 3
- 2
- Recent ratings
- 25
- 0
IQVIA Holdings Inc.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
NRC Health
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Latest IQV
- SEC Form S-8 filed by IQVIA Holdings Inc.
- SEC Form 8-K filed by IQVIA Holdings Inc.
- IQVIA to Announce First-Quarter 2026 Results on May 5, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by IQVIA Holdings Inc.
- IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences
- IQVIA upgraded by TD Cowen with a new price target
- IQVIA upgraded by Barclays with a new price target
- RBC Capital Mkts initiated coverage on IQVIA with a new price target
- IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference
- IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference
Latest NRC
- National Research Corporation filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- Ann & Robert H. Lurie Children's Hospital of Chicago Expands Partnership with NRC Health to Strengthen Consumer Insight and Online Reputation Strategy
- Amendment: SEC Form SCHEDULE 13D/A filed by National Research Corporation
- Piedmont Names NRC Health as a Strategic Experience Partner to Support Mission-Driven Growth
- Executive Vice President Rau Jason Russell was granted 60,000 shares (SEC Form 4)
- NRC Health Announces Board Authorization of $60 Million Share Repurchase Program
- SEC Form S-8 filed by National Research Corporation
- SEC Form 10-K filed by National Research Corporation
- NRC Health Provides Business Update
- EVP & Chief Financial Officer Harrison Shane R bought $98,162 worth of shares (8,000 units at $12.27) (SEC Form 4)